Jacobs Levy Equity Management
BIOA

Jacobs Levy Equity Management’s BioAge Labs BIOA Stock Holding History

Jacobs Levy Equity Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.24M Sell
377,085
-43,038
-10% -$778K 0.03% 326
2026
Q1 		$7.35M Buy
420,123
+85,997
+26% +$1.66M 0.03% 351
2025
Q4 		$4.42M Buy
334,126
+121,038
+57% +$1.07M 0.02% 432
2025
Q3 		$1.25M Sell
213,088
-60,364
-22% -$283K 0.01% 672
2025
Q2 		$1.13M Buy
+273,452
New +$1.1M ﹤0.01% 735

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

Jacobs Levy Equity Management's BIOA Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its BioAge Labs (BIOA) stake by 10% in Q2 2026, selling an estimated $778K and leaving 377,085 shares worth $9.24M. The position accounts for 0.03% of the portfolio, ranked #326.

Jacobs Levy Equity Management first reported a position in BIOA in Q2 2025 and has held it in 5 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • Jacobs Levy Equity Management held 377,085 shares of BioAge Labs worth $9.24M as of Q2 2026.
  • Jacobs Levy Equity Management sold 43,038 BioAge Labs shares in Q2 2026, an estimated $778K.
  • BioAge Labs made up 0.03% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #326 holding.
  • Jacobs Levy Equity Management first reported a position in BioAge Labs in Q2 2025 and has held it in 5 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.